1. Carla B Mellough
  2. Majlinda Lako  Is a corresponding author
  1. Newcastle University, United Kingdom

The manual for human development is written in the genetic code of our DNA. Our genes encode the instructions to make specific types of molecules that are needed to either build the human body or to control its day-to-day operations. The first step in producing these molecules involves the gene being copied, or transcribed, into an RNA molecule. For some genes, this RNA molecule is the end product; for other genes, the RNA molecule must then be translated to produce a protein.

Mistakes, or mutations, in a gene often change the RNA or protein produced, and even the smallest of changes can have far-reaching effects. For example, if these mutations affect molecules that are needed when a human embryo is developing in the womb, they can lead to severe abnormalities that are collectively called congenital disorders. A cleft palate is a relatively common example of a congenital disorder, and affects one in every 700 babies born each year (Forrester and Merz, 2004; Parker et al., 2010). Similarly, mutations that result in genes being active at the wrong time, or in the wrong cells in a developing embryo, can also lead to congenital disorders. In addition, exposure to toxic or infectious agents can also be a cause. This is exemplified by the drug thalidomide, which was administered to pregnant women between 1956 and 1962, and has caused severe birth defects in around 10,000 children worldwide (McBride, 1961).

Understanding why organs sometimes form incorrectly is challenging, largely because tissue from developing human embryos is rarely available for study. Instead, research has tended to extrapolate information from multiple sources, including individuals born with specific disorders, animal models and cell-based laboratory models of development and disease (Azamian and Lalani, 2016; Moretti et al., 2013; Kelly, 2016).

Some studies have investigated which genes are expressed in developing human embryos by looking at the RNA molecules produced at a given time. These “transcriptomics” studies, however, have tended to look at the embryo as a whole (Fang et al., 2010), or to focus on specific organs and tissues in more developed embryos (van den Berg et al., 2015; Slieker et al., 2015). Consequently, little was known about the formation and early development of organs – a process called organogenesis – in humans.

Over the past year or so, data on this crucial process has started to emerge. First, in mid-2015, a study described the transcriptional profiles of human embryos from different developmental stages (Roost et al., 2015). Now, in eLife, Neil Hanley and co-workers – from the University of Manchester and the Central Manchester University Hospitals NHS Foundation Trust – report transcriptomics data obtained during human organogenesis (Gerrard et al., 2016). The human embryonic material used in the study was collected according to the Codes of Practice of the UK Human Tissue Authority (HTA, 2016).

Hanley and co-workers – who include Dave Gerrard and Andrew Berry as joint first authors – looked at the RNA molecules found in organs and tissues from fifteen separate sites in human embryos. These sites included the thyroid, liver, stomach, brain, heart and adrenal gland. Gerrard et al. were then able to integrate this data into a sort of atlas that mapped the activity level of developmental genes across the embryo. This in turn allowed them to identify eleven groups of genes that were expressed differently in the different organs and tissues examined. Gerrard et al. refer to these groups of genes as metagenes and the activity levels of genes found in each metagene form a kind of transcriptional barcode for each of the different tissue types of the body.

Many cell-based models of development use stem cells from human embryos, or other cells that have been reprogrammed to be more like stem cells (so-called induced pluripotent stem cells; Takahashi et al., 2007). However, these approaches have their limitations (Hrvatin et al., 2014; Patterson et al., 2012), and it is challenging to ensure that stem cells differentiate into completely mature tissues in vitro. Gerrard et al. confirmed that the transcriptional barcode associated with the embryonic liver (metagene 2) was also seen in liver tissue derived from stem cells grown in the laboratory. This suggests that the transcriptional barcodes could be used to check that lab-grown stem cells have differentiated and matured as intended. Moreover, knowing which genes actively direct the cells in embryos to differentiate in specific ways could help other researchers to coax stem cells to become a wider range of tissues in vitro.

The work of Gerrard et al. adds substantially to what is known about the transcriptional profiles of each of the organs and tissues in a developing human embryo, and about the disorders associated with these tissues. Furthermore, their findings complement what we know about the later stages of embryonic development (Roost et al., 2015), and will allow a greater understanding of the distinct events that occur during human development and disease.

The findings by Hanley, Gerrard, Berry and colleagues have great implications for improving stem cell research. They will also undoubtedly aid research into diseases that develop at later stages of development, which has proved particularly challenging so far. Might we be on the cusp of completing the last pages of the ‘how to build a human’ manual? If so, soon we may finally be able to generate mature tissues more routinely in vitro and unravel the unknown mechanisms of development and disease.

References

  1. Book
    1. Kelly RG
    (2016)
    Cardiac development and animal models of congenital heart defects
    In: S Rickert-Sperling, RG Kelly, DJ Driscoll, editors. Congenital Heart Diseases: The Broken Heart. Vienna: Springer. pp. 3–9.

Article and author information

Author details

  1. Carla B Mellough

    Institute of Genetic Medicine and North-East England Stem Cell Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3685-6516
  2. Majlinda Lako

    Institute of Genetic Medicine and North-East England Stem Cell Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
    For correspondence
    majlinda.lako@ncl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1327-8573

Publication history

  1. Version of Record published: August 24, 2016 (version 1)

Copyright

© 2016, Mellough et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,025
    views
  • 281
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Carla B Mellough
  2. Majlinda Lako
(2016)
Transcriptomics: How to build a human
eLife 5:e19826.
https://doi.org/10.7554/eLife.19826
  1. Further reading

Further reading

    1. Developmental Biology
    Ruonan Zhao, Emma L Moore ... Paul A Trainor
    Research Article

    Epithelial to mesenchymal transition (EMT) is a cellular process that converts epithelial cells to mesenchymal cells with migratory potential in developmental and pathological processes. Although originally considered a binary event, EMT in cancer progression involves intermediate states between a fully epithelial and a fully mesenchymal phenotype, which are characterized by distinct combinations of epithelial and mesenchymal markers. This phenomenon has been termed epithelial to mesenchymal plasticity (EMP), however, the intermediate states remain poorly described and it’s unclear whether they exist during developmental EMT. Neural crest cells (NCC) are an embryonic progenitor cell population that gives rise to numerous cell types and tissues in vertebrates, and their formation and delamination is a classic example of developmental EMT. However, whether intermediate states also exist during NCC EMT and delamination remains unknown. Through single-cell RNA sequencing of mouse embryos, we identified intermediate NCC states based on their transcriptional signature and then spatially defined their locations in situ in the dorsolateral neuroepithelium. Our results illustrate the importance of cell cycle regulation and functional role for the intermediate stage marker Dlc1 in facilitating mammalian cranial NCC delamination and may provide new insights into mechanisms regulating pathological EMP.

    1. Developmental Biology
    Thierry Gilbert, Camille Gorlt ... Andreas Merdes
    Research Article Updated

    Ninein is a centrosome protein that has been implicated in microtubule anchorage and centrosome cohesion. Mutations in the human NINEIN gene have been linked to Seckel syndrome and to a rare form of skeletal dysplasia. However, the role of ninein in skeletal development remains unknown. Here, we describe a ninein knockout mouse with advanced endochondral ossification during embryonic development. Although the long bones maintain a regular size, the absence of ninein delays the formation of the bone marrow cavity in the prenatal tibia. Likewise, intramembranous ossification in the skull is more developed, leading to a premature closure of the interfrontal suture. We demonstrate that ninein is strongly expressed in osteoclasts of control mice, and that its absence reduces the fusion of precursor cells into syncytial osteoclasts, whereas the number of osteoblasts remains unaffected. As a consequence, ninein-deficient osteoclasts have a reduced capacity to resorb bone. At the cellular level, the absence of ninein interferes with centrosomal microtubule organization, reduces centrosome cohesion, and provokes the loss of centrosome clustering in multinucleated mature osteoclasts. We propose that centrosomal ninein is important for osteoclast fusion, to enable a functional balance between bone-forming osteoblasts and bone-resorbing osteoclasts during skeletal development.